Stella Babich, Pier Giorgio Cojutti, Milo Gatti, Federico Pea, Stefano Di Bella, Jacopo Monticelli:Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditis. In: JAC-Antimicrobial Resistance. Band7, Nr.3, 29.April 2025, doi:10.1093/jacamr/dlaf066, PMC12050970(freier Volltext).
T. Tängdén, C. G. Giske: Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.Journal of Internal Medicine, Band 277 (2015), S. 501-12.T, doi:10.1111/joim.12342
Robert A Bonomo:Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens. In: Clinical Infectious Diseases. Band69, Supplement_7, 13.November 2019, S.S519–S520, doi:10.1093/cid/ciz823, PMID 31724046, PMC6853757(freier Volltext).
Stella Babich, Pier Giorgio Cojutti, Milo Gatti, Federico Pea, Stefano Di Bella, Jacopo Monticelli:Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditis. In: JAC-Antimicrobial Resistance. Band7, Nr.3, 29.April 2025, doi:10.1093/jacamr/dlaf066, PMC12050970(freier Volltext).